High-throughput SARS-CoV-2 Antigen (CoV2Ag) Assays* by Siemens Healthineers

Manufacturer Siemens Healthineers  |  Available Worldwide
Lab-based antigen testing for rapid virus detection: Time to first result in as little as 26 minutes.


High-throughput SARS-CoV-2 Antigen (CoV2Ag) Assays* by Siemens Healthineers product image
High-throughput SARS-CoV-2 Antigen (CoV2Ag) Assays*
Request Pricing

Receive your quote directly from the manufacturer.



0 Scientists have reviewed this product


Write the First Review

No Reviews

The Siemens Healthineers SARS-CoV-2 Antigen (CoV2Ag) Assays are for in vitro diagnostic use in the qualitative detection of SARS-CoV-2 nucleocapsid in nasopharyngeal swab and anterior nasal specimens from individuals who are suspected of COVID-19 by their healthcare provider within the first seven days of symptom onset, or from asymptomatic individuals, using the Atellica® IM Analyzer or ADVIA Centaur® XP/XPT Immunoassay Systems. These assays are intended as an aid in the diagnosis of patients with suspected SARS-CoV-2 infection.

Atellica IM and ADVIA Centaur SARS-CoV-2 Antigen Assays:

  • Save time and resources while increasing testing capacity and confidence.
  • Support quick detection of positive cases, allowing protective measures and appropriate follow up.
  • Help protect your laboratory staff with a pretreatment to inactivate the virus.

*This test has not been reviewed by the FDA. In the U.S., use of this test is limited to laboratories that are certified under Clinical Laboratory Improvement Amendments of 1988 (CLIA) to perform high-complexity testing. Product availability may vary by country and is subject to regulatory requirements.

Product Overview

High-throughput SARS-CoV-2 Antigen (CoV2Ag) Assays* by Siemens Healthineers product image

High-throughput SARS-CoV-2 Antigen (CoV2Ag) Assays*

Manufacturer Siemens Healthineers  |  Available Worldwide

Be the first to review this product